Precision oncology in endometrial cancer
1 Views
administrator
07/17/23
Alexandra Leary, MD, PhD, Gustave Roussy Institute, Villejuif, France, discusses where we are in terms of precision medicine for patients with endometrial cancer. Precision medicine uses genetic or molecular profiling to optimize efficiency or therapeutic benefit for patients with endometrial cancer, highlighting the use of immune checkpoint inhibitors in mismatch repair deficient patients. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.
-
Category
Show more
Facebook Comments
No comments found